Picture Bionordic Nordic Life Science Days 2018 Stockholm 600x60px

News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 4300 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 6 7 8 ... 42 43 44  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Macrophage Pharma Ltd.. (5/11/17). "Press Release: Macrophage Pharma Appoints Development Director. Dr Joanne Bedwell-Garner Joins Management Team". 2017-05-11
Scancell Holdings plc. (5/11/17). "Press Release: Placing Raises £5.0 Million, Issue of Equity and PDMR Shareholding [Not for relase in, into or from any jurisdiction where this would constitute a violation of relavant laws or regulations]". 2017-05-11
ThromboGenics N.V.. (5/11/17). "Press Release: ThromboGenics Business Update – Q1 2017. Progressing Innovative Diabetic Eye Disease Clinical and Pre-Clinical Portfolio". Leuven. 2017-05-11
Adaptimmune Therapeutics plc. (5/10/17). "Press Release: Adaptimmune Announces Initiation of Study to Evaluate SPEAR T-Cell Therapy Targeting AFP in Liver Cancer". Philadeliphia, PA & Oxford. 2017-05-10
Enyo Pharma S.A.. (5/10/17). "Press Release: Enyo Pharma Strengthens Its Business Team to Support International Growth". Lyon. 2017-05-10
Adaptimmune Therapeutics plc. (5/10/17). "Press Release: Adaptimmune Reports First Quarter 2017 Financial Results". Philadeliphia, PA & Oxford. 2017-05-10
Evotec AG. (5/10/17). "Press Release: Evotec Announces First Quarter 2017 Results and Corporate Update". Hamburg. 2017-05-10
Takeda Pharmaceutical Co. Ltd.. (5/9/17). "Press Release: Takeda Terminates Plans for Vaxem Hib Launch in Japan Due to the Vaccine Supplier’s (GSK) Decision to Discontinue Global Production". Osaka. 2017-05-09
Takeda Pharmaceutical Co. Ltd.. (5/9/17). "Press Release: Takeda and GammaDelta Therapeutics Announce Collaboration to Advance Tissue-derived Gamma Delta (gd) T Cells". Osaka & London. 2017-05-09
Microbiotica Ltd.. (5/9/17). "Press Release: Microbiotica Appoints John Shields as Non-Executive Director". 2017-05-09
BC Platforms. (5/9/17). "Press Release: BC Platforms Closes USD $10 Million Series B Financing Led by Debiopharm and Tesi to Accelerate Knowledge Platform Development". 2017-05-09
Exscientia Ltd.. (5/9/17). "Press Release: Exscientia Announces EUR 250 Million Collaboration for Multiple-product Development and Licence Option Agreement with Sanofi". 2017-05-09
Sygnis AG. (5/8/17). "Press Release: Sygnis AG Plans to Acquire Profitable Innova Biosciences Ltd. for EUR 8 Million in Cash and up to 3.5 Million Shares [Not for USA, Canada, Japan and Australia]". Madrid & Heidelberg. 2017-05-08
Consilium Strategic Communications Ltd.. (5/8/17). "Press Release: Consilium Strategic Communications Strengthens Senior International Healthcare Team with the Appointment of Philippa Gardner and Suki Virji". London. 2017-05-08
PolyPico Technologies Ltd.. (5/8/17). "Press Release: Precision Gets a Whole New Meaning with the Launch of the PicoPRECISE". Galway. 2017-05-08
Fluidigm Corporation. (5/4/17). "Press Release: European Mass Cytometry Consortium Brings CyTOF Technology to Leading Universities to Advance Clinical Research". South San Francisco, CA. 2017-05-04
Fluidigm Corporation. (5/4/17). "Press Release: Fluidigm Announces First Quarter Financial Results". South San Francisco, CA. 2017-05-04
Thermo Fisher Scientific Inc.. (5/4/17). "Press Release: New Licensing Program Facilitates Adoption of Tandem Mass Tag Technology". Carlsbad, CA. 2017-05-04
MiNA Therapeutics Ltd.. (5/3/17). "Press Release: Sosei Pays GBP 35 Million for an Equity Stake and Acquisition Option Agreement in MiNA Therapeutics". Tokyo & London. 2017-05-03
GammaDelta Therapeutics Ltd.. (5/3/17). "Press Release: GammaDelta Therapeutics Expands Management Team Led by Paolo Paoletti as CEO". London. 2017-05-03
Pieris Pharmaceuticals, Inc.. (5/3/17). "Press Release: Pieris Pharmaceuticals and AstraZeneca Collaborate to Develop and Commercialize Anticalin-based Inhaled Treatments for Respiratory Diseases". Boston, MA. 2017-05-03
Cambridge Enterprise. (5/3/17). "Press Release: Spin-out Z Factor Announces £7 million Series A Funding to Bring Lung Treatment to the Clinic". 2017-05-03
Metrion Biosciences Ltd.. (5/2/17). "Press Release: Metrion Biosciences Appoints Chief Operating Officer and Head of Business Development". Cambridge. 2017-05-02
Bluebird Bio, Inc.. (5/2/17). "Press Release: Bluebird Bio Enters Lentiviral Vector Patent License Agreement with GlaxoSmithKline for Commercialization of Gene Therapies". Cambridge, MA. 2017-05-02
Adaptimmune Therapeutics plc. (5/2/17). "Press Release: Adaptimmune to Present at Upcoming Deutsche Bank 42nd Annual Health Care Conference". Philadeliphia, PA & Oxford. 2017-05-02
Varex Imaging Corporation. (5/1/17). "Press Release: Varex Imaging Completes Acquisition of PerkinElmer's Medical Imaging Business". Salt Lake City, UT. 2017-05-01
PerkinElmer, Inc.. (5/1/17). "Press Release: PerkinElmer Completes Sale of Medical Imaging Business to Varex Imaging". Waltham, MA. 2017-05-01
AstraZeneca plc. (5/1/17). "Press Release: AstraZeneca’s Imfinzi (durvalumab) Receives US FDA Accelerated Approval for Previously Treated Patients with Advanced Bladder Cancer". 2017-05-01
Medigene AG. (4/28/17). "Press Release: Medigene Announces Participation at Six International Conferences". Planegg. 2017-04-28
Verona Pharma plc. (4/27/17). "Press Release: Verona Pharma Announces Pricing of Global Offering and Approval to List on the NASDAQ Global Market [Not for any jurisdiction where distribution would constitute a violation of relevant laws]". London. 2017-04-27
Sygnis AG. (4/27/17). "Press Release: Sygnis AG Reports Financial Results for Fiscal Year 2016". Madrid & Heidelberg. 2017-04-27
Novacyt S.A.. (4/27/17). "Press Release: Novacyt Full Year 2016 Results". Paris & Cambridge. 2017-04-27
Congenica Ltd.. (4/27/17). "Press Release: Congenica Completes Series B Financing Round with Investments from China-based BGI, Healthlink and Future Planet". Cambridge. 2017-04-27
Microsaic Systems plc. (4/26/17). "Press Release: Integration with SCPA Chromatography Software". 2017-04-26
Arsanis, Inc.. (4/26/17). "Press Release: Arsanis Completes $45.5 Million Series D Financing". Waltham, MA & Vienna. 2017-04-26
Forge Therapeutics, Inc.. (4/25/17). "Press Release: Forge Therapeutics Raises $15m Series A Financing to Develop First Novel Gram-negative Antibiotic in Decades". San Diego, CA. 2017-04-25
Enamine Ltd.. (4/25/17). "Press Release: Enamine to Collaborate with EMBL for Cancer Drug Discovery Research". Kiev. 2017-04-25
Sygnis AG. (4/24/17). "Press Release: Sygnis AG Expands Access to Chinese Market with Second OEM Deal with Tanon". Madrid & Heidelberg. 2017-04-24
Metrion Biosciences Ltd.. (4/24/17). "Press Release: Metrion Biosciences and Venomtech Announce Research Collaboration". Cambridge. 2017-04-24
Bruker Corporation. (4/21/17). "Press Release: Bruker Introduces New Clinical Microbiology Assays and Kits at ECCMID". Vienna. 2017-04-21
Evolva Holding S.A.. (4/20/17). "Press Release: Gerard Hoetmer, Formerly at Unilever and Corbion, Proposed to Succeed Sir Tom McKillop as Evolva Chairman". Switzerland. 2017-04-20
Redx Pharma plc. (4/20/17). "Press Release: Appointment of Chairman". 2017-04-20
Curetis N.V.. (4/20/17). "Press Release: Curetis’ Unyvero Intra-Abdominal Infection (IAI) Cartridge Receives CE Marking". Amsterdam & Holzgerlingen. 2017-04-20
Advent France Biotechnology S.A.S.. (4/20/17). "Press Release: Advent France Biotechnology Announces Its First Life Sciences Dedicated Seed-Fund with a First Closing at €64.75M (USD68.5M)". Paris. 2017-04-20
OBN (UK) Ltd.. (4/20/17). "Press Release: OBN Appoints New Director to Enhance Board Expertise". Abingdon. 2017-04-20
Bicycle Therapeutics Ltd.. (4/20/17). "Press Release: Bicycle Therapeutics Announces a Candidate Preclinical Milestone in Its Ophthalmology Alliance with Thrombogenics". Cambridge, MA & Cambridge. 2017-04-20
Oxford Cancer Biomarkers Ltd.. (4/19/17). "Press Release: Oxford Cancer Biomarkers Announces Strategic Collaboration with My-BioMed Biotechnology Co. Ltd.". Oxford. 2017-04-19
Cobra Biologics Ltd.. (4/18/17). "Press Release: Cobra Biologics Embarks On £15m (165m SEK) Gene Therapy Manufacturing Operations Expansion". Keele & Matfors & Södertälje. 2017-04-18
CRISPR Therapeutics AG. (4/13/17). "Press Release: CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appeal of CRISPR/Cas9 U.S. Patent Board Decision". Basel, et al.. 2017-04-13
HiberGene Diagnostics Ltd.. (4/12/17). "Press Release: HiberGene Closes €6.7m Series B Funding Round". Dublin. 2017-04-12
Endo International plc. (4/12/17). "Press Release: Endo International plc Announces Pricing of Private Offering of Senior Secured Notes". Dublin. 2017-04-12
Sygnis AG. (4/11/17). "Press Release: Sygnis AG Successfully Completes Integration of Recently Acquired C.B.S. Scientific". Madrid & Heidelberg. 2017-04-11
Optibrium Ltd.. (4/11/17). "Press Release: Lhasa and Optibrium Enter Research and Product Development Collaboration". Cambridge & Leeds. 2017-04-11
Adaptimmune Therapeutics plc. (4/10/17). "Press Release: Adaptimmune Therapeutics plc Announces Closing of $42 Million Registered Direct Offering". Philadeliphia, PA & Oxford. 2017-04-10
Endo International plc. (4/10/17). "Press Release: Endo International plc Announces Proposed Private Offering of Senior Secured Notes". Dublin. 2017-04-10
Consilium Strategic Communications Ltd.. (4/10/17). "Press Release: Consilium Strategic Communications and Westwicke Partners Enter into Joint Venture for Healthcare Focused US IR Advisory". London & Baltimore, MD. 2017-04-10
Pirbright Institute, The. (4/7/17). "Press Release: Dr. Bryan Charleston Appointed as Director of The Pirbright Institute". 2017-04-07
Microsaic Systems plc. (4/7/17). "Press Release: Microsaic Signs Amended Agreement with Global Partner". 2017-04-07
Novacyt S.A.. (4/6/17). "Press Release: Novacyt Announces Bond Issue". Paris & Cambridge. 2017-04-06
bioMérieux S.A.. (4/6/17). "Press Release: bioMérieux Receives FDA 510(k) Clearance for its BacT/Alert VIRTUO Fully Automated Blood Culture System". Marcy l’Étoile. 2017-04-06
MGB Biopharma Ltd.. (4/6/17). "Press Release: MGB Biopharma Closes $1 Million Financing Round to Finance Manufacturing of MGB-BP-3 for Phase II Study in Clostridium difficile-Associated Disease (CDAD)". Glasgow. 2017-04-06
SkinBioTherapeutics plc. (4/5/17). "Press Release: First Day of Dealings. Company to Trade under Ticker Code SBTX [Not for US, AU, CA, JP, ZA, IE, et al.]". Manchester. 2017-04-05
Adaptimmune Therapeutics plc. (4/5/17). "Press Release: Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares". Philadeliphia, PA & Oxford. 2017-04-05
Heptares Therapeutics Ltd.. (4/5/17). "Press Release: Heptares to Receive US$12 Million Milestone Payment from AstraZeneca". London. 2017-04-05
Bicycle Therapeutics Ltd.. (4/3/17). "Press Release: Bicycle Therapeutics Announces Presentations at the 2017 American Association for Cancer Research Annual Meeting". Cambridge, MA & Cambridge. 2017-04-03
Cellnovo. (4/3/17). "Press Release: Cellnovo Appoints Erwan Martin as Chief Financial Officer". Paris. 2017-04-03
AstraZeneca plc. (3/31/17). "Press Release: Tagrisso (osimertinib) Receives US FDA Full Approval". 2017-03-31
Redx Pharma plc. (3/30/17). "Press Release: Redx Pharma Awarded US$1 Million Grant by CARB-X". 2017-03-30
Oxford BioMedica plc. (3/30/17). "Press Release: Oxford BioMedica Notes Acceptance by FDA of a Biologics License Application (BLA) Filing for CTL019". Oxford. 2017-03-30
Forge Therapeutics, Inc.. (3/30/17). "Press Release: Forge Therapeutics Wins Powered by CARB-X Research Award of $8.8M to Accelerate Development of its LpxC Antibiotic to Kill the World's Deadliest 'Superbugs'". San Diego, CA. 2017-03-30
Genomics Medicine Ireland Ltd.. (3/30/17). "Press Release: Genomics Medicine Ireland Announces Two Appointments to Its Board. Dr. Kari Stefánsson and Dr. Paul Saunders Appointed to the Board". Dublin. 2017-03-30
CARB-X. (3/30/17). "Press Release: CARB-X injects up to $48 million to accelerate first Powered by CARB-X portfolio of drug discovery and development projects to tackle antibiotic resistance". Washington, DC & London. 2017-03-30
Biotest AG. (3/29/17). "Press Release: Discussions Regarding Possible Business Combination". Dreieich. 2017-03-29
Novartis AG. (3/29/17). "Press Release: Novartis Announces First CAR-T Cell Therapy BLA for Pediatric and Young Adult Patients with r/r B-cell ALL Granted FDA Priority Review". Basel. 2017-03-29
Evotec AG. (3/28/17). "Press Release: Evotec Fiscal Year Results 2016. Leading Innovation Efficiency and First-in-class Drug Discovery". Hamburg. 2017-03-28
Linguamatics Ltd.. (3/28/17). "Press Relase: Linguamatics and Dow Jones Partner to Accelerate Pharma Industry Research". Cambridge & Boston, MA. 2017-03-28
CRISPR Therapeutics AG. (3/28/17). "Press Release: CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene Editing". Basel. 2017-03-28
Adaptimmune Therapeutics plc. (3/27/17). "Press Release: Adaptimmune Therapeutics plc Announces Closing of Public Offering and Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares". Philadeliphia, PA & Oxford. 2017-03-27
Cosmo Pharmaceuticals N.V.. (3/27/17). "Press Release: Cosmo Announces further Expansion of Endoscopy Pipeline with Filing for EU Approval of New Medical Device Qolotag to Enhance Diagnosis in Sigmoidoscopies". Dublin. 2017-03-27
InSphero AG. (3/27/17). "Press Release: InSphero 3D Liver Microtissues Featured at Annual SOT Meeting as More Sensitive Model for DILI and Mechanistic Toxicity Testing". Schlieren. 2017-03-27
Adaptimmune Therapeutics plc. (3/27/17). "Press Release: Adaptimmune to Participate in Upcoming Jefferies Immuno-Oncology Summit". Philadeliphia, PA & Oxford. 2017-03-27
PureTech Health plc. (3/24/17). "Press Release: PureTech Health Announces Licensing and Equity Agreement with Novartis to Advance Clinical Stage mTORC1 Programs". Boston, MA. 2017-03-24
Cancer Research UK. (3/24/17). "Press Release: New Era in Precision Medicine for Pancreatic Cancer". 2017-03-24
Numares AG. (3/23/17). "Press Release: Numares AG and Oxford University to Collaborate on Development of Multiple Sclerosis Diagnostic Test". Regensburg & Oxford. 2017-03-23
Unit DX. (3/23/17). "Press Release: Our Opening Event. The future looks bright for Science in Bristol". 2017-03-23
BioLineRx Ltd.. (3/23/17). "Press Release: BioLineRx Announces Acquisition of Agalimmune Ltd. to Accelerate Expansion of Immuno-Oncology Pipeline". Tel Aviv. 2017-03-23
Adaptimmune Therapeutics plc. (3/22/17). "Press Release: Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares". Philadeliphia, PA & Oxford. 2017-03-22
Regeneron Pharmaceuticals, Inc.. (3/22/17). "Press Release: U.K. Biobank, Regeneron and GSK Announce Largest Gene Sequencing Initiative on World's Most Detailed Health Database to Improve Drug Discovery and Disease Diagnosis". Tarrytown, NY. 2017-03-22
Microsaic Systems plc. (3/21/17). "Press Release: Audited Financial Results for the Year Ended 31 December 2016". 2017-03-21
Thermo Fisher Scientific Inc.. (3/21/17). "Press Release: Thermo Fisher Scientific and the Cell and Gene Therapy Catapult Collaborate to Optimise Advanced Therapy Supply Chain". London. 2017-03-21
OptiBiotix Health plc. (3/21/17). "Press Release: Intention to Float SkinBioTherapeutics". 2017-03-21
Adaptimmune Therapeutics plc. (3/21/17). "Press Release: Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares". Philadeliphia, PA & Oxford. 2017-03-21
Redx Pharma plc. (3/21/17). "Press Release: Final Results for the Year Ended 30 September 2016". 2017-03-21
Pulmocide Ltd.. (3/20/17). "Press Release: Pulmocide Raises $30 Million in Series B Financing. Funding to Progress Novel Wholly-owned Compounds for RSV and Pulmonary Aspergillosis". London. 2017-03-20
GlaxoSmithKline GmbH & Co. KG. (3/20/17). "Pressemitteilung: Spatenstich bei GSK in Marburg für eine 162 Mio € Meningokokken-B-Impfstoff-Produktion". 2017-03-20
AstraZeneca plc. (3/17/17). "Press Release: AstraZeneca Receives Complete Response Letter from US FDA for ZS-9 (sodium zirconium cyclosilicate) for Hyperkalaemia". 2017-03-17
AstraZeneca plc. (3/17/17). "Press Release: AstraZeneca and Circassia Enter Strategic Collaboration in Respiratory Disease". 2017-03-17
Eurofins Scientific UK. (3/17/17). "Press Release: Eurofins to Invest Millions in New UK Facility". 2017-03-17
Cell Medica Ltd.. (3/16/17). "Press Release: £60 Million Series C Financing to Advance Multiple Cancer Programmes". London. 2017-03-16
Coulter Partners. (3/15/17). "Press Release: Coulter Partners Announces Further Swiss Expansion with New Office in Zurich". 2017-03-15
next pagenext page 1 2 3 ... 6 7 8 ... 42 43 44  next pagenext page


Picture [LSG] – The Business Web Portal 600x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group BioPharm America 2018 Boston September 600x60px

» top